Apple: Analysts Anticipate Q3 Revenues Of $73.3 Billion

Apple (NASDAQ: AAPL) will be reporting their fiscal third quarter on July 27th after market close. Analysts have a consensus $159.98 12-month price target on the company, via a total of 41 analysts, with 12 analysts having strong buy ratings. 21 analysts meanwhile have buy ratings, 7 have hold ratings, and one has a strong sell on the company. The street high comes from Wedbush Securities with a $185 price target, and the lowest target sits at $125 from Wolfe Research.

25 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 25 analysts is $73.276 billion; this number has been revised upwards from $66.284 billion at the start of the year. The highest revenue estimate is $77.054 billion, while the lowest is $65.682 billion.

Onto EBITDA estimates, there are currently only 9 analysts who have third-quarter EBITDA estimates. The mean is currently $22.516 billion, with this number having been revised up from $18.4 billion at the start of the year. Street high is a $24.44 billion EBITDA estimate and the lowest is $18.868 billion.

Analysts estimate that quarterly earnings per share will come in at $1.01, with this number being revised up from $0.76 at the start of the year. Street high is currently $1.16 and the lowest estimate is $0.82 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Risk Assets May Have Already Peaked | Mike McGlone

A $3 Billion Gold Deal Just Changed the Market | G Mining Acquires G2 Goldfields

Why the Market May Be Misreading Iran | David Woo

Recommended

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Related News

Canaccord: CloudMD’s Third Quarter Results Were “In The Range Of Expectations”

On November 30th, CloudMD Software & Services (TSXV: DOC) reported its third-quarter financial results. CloudMD...

Tuesday, December 1, 2020, 03:41:00 PM

Small Pharma: Canaccord Initiates Coverage With $1.00 Price Target

Canaccord Genuity recently initiated coverage on Small Pharma Inc (TSXV: DMT), a company that is...

Sunday, June 13, 2021, 01:08:00 PM

Lululemon: Q1 2021 Consensus Analyst Estimates

Lululemon (NASDAQ: LULU) will be reporting their first quarter financial results on June 3rd after...

Thursday, June 3, 2021, 02:02:00 PM

Valens Sees Eight Capital, Haywood, Canaccord Slash Price Targets Following Q2 Financials

Last Wednesday, The Valens Company (TSX: VLNS) released its financial statements for the second quarter...

Monday, July 20, 2020, 11:04:54 AM

Sundial Growers: Analysts Expect Positive EBITDA For Second Quarter

Sundial Growers Inc. (Nasdaq: SNDL) announced that they will be reporting their second quarter financials...

Wednesday, August 11, 2021, 11:58:00 AM